Literature DB >> 8395824

Molecular cloning of a functional human thyrotropin-releasing hormone receptor.

V Matre1, H E Karlsen, M S Wright, I Lundell, A K Fjeldheim, O S Gabrielsen, D Larhammar, K M Gautvik.   

Abstract

A cDNA encoding the human thyrotropin-releasing hormone receptor (hTRH-R) was isolated from a human brain cDNA library. Screening of 1.2 million clones resulted in 2 candidates. The largest clone contained TRH-R homologous sequences starting in the third transmembrane domain and included a long 3' untranslated sequence. The smaller clone contained a potential start of the open reading frame, but was interrupted by an intron in the sixth transmembrane domain. The two clones had 497 bp of overlapping identical sequences and it was possible to assemble a complete cDNA thus restoring the assumed coding sequence. Electrophysiological studies of frog oocytes injected with in vitro transcribed mRNA showed TRH-specific inward currents, demonstrating that the reconstituted cDNA encoded a functional receptor. The predicted amino acid sequence of the hTRH-R protein showed high homology with the rat and mouse TRH-Rs with the exception of their C-terminal region. The human TRH-R gene seems to contain two introns.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395824     DOI: 10.1006/bbrc.1993.2027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.

Authors:  Vilborg Matre; Per I Høvring; Ase-Karine Fjeldheim; Lars Helgeland; Christophe Orvain; Kristin B Andersson; Kaare M Gautvik; Odd S Gabrielsen
Journal:  Biochem J       Date:  2003-06-15       Impact factor: 3.857

2.  Intravenous and Intratracheal Thyrotropin Releasing Hormone and Its Analog Taltirelin Reverse Opioid-Induced Respiratory Depression in Isoflurane Anesthetized Rats.

Authors:  James D Boghosian; Anita Luethy; Joseph F Cotten
Journal:  J Pharmacol Exp Ther       Date:  2018-04-19       Impact factor: 4.030

Review 3.  Neuroregulation of ProTRH biosynthesis and processing.

Authors:  E A Nillni
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

4.  Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice.

Authors:  Chhuttan L Meena; Shubdha Ingole; Satyendra Rajpoot; Avinash Thakur; Prajwal P Nandeker; Abhay T Sangamwar; Shyam S Sharma; Rahul Jain
Journal:  RSC Adv       Date:  2015-06-23       Impact factor: 3.361

5.  Structural insights into ligand binding and activation of the human thyrotropin-releasing hormone receptor.

Authors:  Youwei Xu; Hongmin Cai; Chongzhao You; Xinheng He; Qingning Yuan; Hualiang Jiang; Xi Cheng; Yi Jiang; H Eric Xu
Journal:  Cell Res       Date:  2022-04-01       Impact factor: 46.297

6.  The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.

Authors:  N J Coupland; J E Bailey; P Glue; D J Nutt
Journal:  Br J Clin Pharmacol       Date:  1995-09       Impact factor: 4.335

7.  Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.

Authors:  Nanthakumar Thirunarayanan; Eshel A Nir; Bruce M Raaka; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2012-12-11       Impact factor: 7.853

8.  Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Authors:  Naotake Kobayashi; Norihito Sato; Yuko Fujimura; Tsuyoshi Kihara; Katsuji Sugita; Kouji Takahashi; Katsumi Koike; Tamio Sugawara; Yukio Tada; Hiroshi Nakai; Takayoshi Yoshikawa
Journal:  ACS Omega       Date:  2018-10-19

9.  TRH-receptor-type-2-deficient mice are euthyroid and exhibit increased depression and reduced anxiety phenotypes.

Authors:  Yuhua Sun; Bojana Zupan; Bruce M Raaka; Miklos Toth; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2008-12-10       Impact factor: 7.853

10.  Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor.

Authors:  Nanthakumar Thirunarayanan; Bruce M Raaka; Marvin C Gershengorn
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-09       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.